Merck & Co Inc $60.11

up +0.11


29/8/2014 04:01 PM  |  NYSE : MRK  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get MRK Trend Analysis - it has outperformed the S&P 500 by 5%

Partner Headlines

  1. 4 Biotechs That Might Be Bought Soon

    IBD
  2. I Am Sure This Pharma-Company Suits Your Portfolio

    GuruFocus
  3. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

    GuruFocus
  4. Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend

    Benzinga
  5. Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)

    Benzinga
  6. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

    Benzinga
  7. UPDATE: Deutsche Bank Initiates Coverage On Merck

    Benzinga
  8. Merck, Pfizer combining drugs

    IBD
  9. Fast Money Halftime Report Final Trade From August 26

    Benzinga
  10. Merck, Pfizer Combining Drugs In Lung Cancer Study

    IBD
  11. Pfizer, Merck Report Collaboration on Study Evaluating Novel Anti-Cancer ...

    Benzinga
  12. US Stock Futures Rise Ahead Of Economic Data

    Benzinga
  13. Advaxis, Merck to Collaborate on Investigational Combination of Two Novel ...

    Benzinga
  14. Achillion Pharmaceuticals Up On Buyout Rumors

    IBD
  15. Biotech Leader Gilead Sciences Scores Sovaldi Win

    IBD
  16. Gilead Wins Sovaldi Dispute With Roche, U.K. Nod

    IBD
  17. Stocks Backslide Into Losses; Jazz Pharma, Kinder Morgan Rise

    IBD
  18. Buyback ETF Slow-Footed: Better Ideas Here

    YCharts
  19. Merck Issues Statement Related to Role of PNEUMOVAX 23 in Updated ACIP ...

    Benzinga
  20. UPDATE: FDA Approves Belsomra Tablets for Use as Sleep Aid

    Benzinga
  21. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD
  22. Legendary Investor Irving Kahn's Top Five Stocks

    GuruFocus
  23. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga
  24. 3 Reasons to Buy Merck for the Long Term

    Benzinga
  25. Len Schleifer's Science Focus Pays Off At Regeneron

    IBD
  26. Merck, J&J, Baxter Provide Healthy Dividend Stream

    IBD
  27. Amgen To Slash Workforce

    IBD
  28. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties

    Benzinga
  29. Pharmaceutical ETFs Are Health Care Sector Standouts

    Benzinga
  30. Indices Remain Mixed; Merck Beats Expectations

    Benzinga
  31. Tuesday Morning Earnings Releases

    Benzinga
  32. Herbalife Falls On Downbeat Results; Windstream Shares Spike Higher

    Benzinga
  33. Merck, Pfizer Beat Q2 Earnings Estimates

    IBD
  34. Markets Open Higher; Merck Posts Upbeat Profit

    Benzinga
  35. Stocks Climb In Early Trade; Herbalife, El Pollo Loco Dive

    IBD
  36. Stock Futures Show Some Muscle; Merck, Cognex Rising

    IBD
  37. US Stock Futures Rise Ahead Of Earnings, Consumer Confidence Data

    Benzinga
  38. UPDATE: Merck Q2 Profit Beats Street View, Shares Rise

    Benzinga
  39. Earnings Scheduled For July 29, 2014

    Benzinga
  40. Stocks To Watch For July 29, 2014

    Benzinga
  41. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga
  42. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  43. Earnings Expectations For The Week Of July 28: Exxon, Pfizer, Twitter And ...

    Benzinga
  44. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  45. Week Ahead: July Jobs Report, FOMC and GDP

    FoxBusiness
  46. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  47. UnitedHealth Group Up on Weak Day for the Dow

    GuruFocus
  48. U.S. Markets Regain Losses from Last Week

    GuruFocus
  49. Abner Herrman Is Increasing Position in the Pharmaceutical Sector

    GuruFocus
  50. Senators Ask Gilead To Explain Sovaldi Pricing

    IBD
Trading Center